Sanofi Appoints Dr. Gary J. Nabel as Chairman of the Strategic Development and Scientific Advisory Council
Sanofi is pleased to announce today the appointment of Dr. Gary J. Nabel, M.D., Ph.D., to Chairman of the Strategic Development and Scientific Advisory Council (SDSAC).
Dr. Nabel, currently Senior Vice President, Chief Scientific Officer and Deputy to Dr. Elias Zerhouni, President, Global R&D, will succeed Dr. Richard Klausner. As part of his key responsibilities as Chief Scientific Officer for global R&D, Dr. Nabel will direct the activities of the Council, including selection, appointment and evaluation of advisers.
Created in November 2010, the Council is a unique structure developed to enhance scientific discovery in a collaborative approach and to further develop a truly world-class research and development platform for future innovation for the benefit of patients around the world.
The role of the Council is to advise Sanofi on new and emerging areas of science and technology as well as deepen Sanofi relationship with the external scientific world by creating a strong network of scientists and institutional partnerships.
Dr. Richard Klausner occupied this position since March 1, 2011, providing overall direction and scientific leadership together with some of the most talented scientists around the world across the continuum from Discovery to Development to Delivery.
